DIADEME’ project awarded €6.5 million in government funding via France 2030, enabling Ciloa to advance development of its bio-drug APN-sEV (Adiponectin associated with exosomes), the world’s only ...

French biotech Ciloa is joining the race to treat type 2 diabetes and obesity, armed with 6.5 million euros ($7.6 million) in ...

It’s been a fast-paced week in the world of startups and tech innovation, with news flying in from all corners — funding rounds, strategic partnerships, ...

Prioritizing high-fiber foods, like lentils, raspberries, avocados, Brussels sprouts, oat groats, and chia seeds, can help ...

This review explores the potential of punicic acid in pomegranate seed oil as a nutraceutical for cardiovascular health.

Obesity is defined by chronic low-grade inflammation in the body. Fat cells, particularly dysfunctional ones, release ...

Obesity research and facts. Read the latest medical research on obesity. Evaluate weight loss programs and choose a diet plan based on your health and lifestyle needs.

Top-line phase 2 results with Amgen's MariTide drug for obesity are finally in, but don't seem to have lived up to investor expectations.

Shares in Eli Lilly rose sharply in pre-market trading today after the company reported the first phase 3 results for orforglipron, a GLP-1 agonist that it hopes will offer an oral alternative to ...

An atlas study of adipose tissue in people with obesity undergoing weight loss and their lean counterparts reveals that weight loss reduces cell senescence but cannot reverse all the metabolic ...